244 related articles for article (PubMed ID: 25091505)
41. Characterization of receptors mediating 5-hydroxytryptamine- and catecholamine-induced platelet aggregation, assessed by the actions of alpha- and beta-blockers, butyrophenones, 5-HT antagonists and chlorpromazine.
Boullin DJ; Glenton PA
Br J Pharmacol; 1978 Apr; 62(4):537-42. PubMed ID: 26445
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
Glusa E; Markwardt F
Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
[TBL] [Abstract][Full Text] [Related]
43. Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake.
Lopez-Vilchez I; Diaz-Ricart M; White JG; Escolar G; Galan AM
Cardiovasc Res; 2009 Nov; 84(2):309-16. PubMed ID: 19541671
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of serotonin transporters by cocaine and meprylcaine through 5-TH2C receptor stimulation facilitates their seizure activities.
Morita K; Hamamoto M; Arai S; Kitayama S; Irifune M; Kawahara M; Kihira K; Dohi T
Brain Res; 2005 Sep; 1057(1-2):153-60. PubMed ID: 16125150
[TBL] [Abstract][Full Text] [Related]
45. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.
Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S
Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775
[TBL] [Abstract][Full Text] [Related]
46. Shape change and aggregation of blood platelets: interaction between the effects of adenosine and diphosphate, 5-hydroxytryptamine and adrenaline.
Michal F; Motamed M
Br J Pharmacol; 1976 Feb; 56(2):209-18. PubMed ID: 1252669
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
Stenfors C; Yu H; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
[TBL] [Abstract][Full Text] [Related]
48. The actions of flupenthixol upon 5-hydroxytryptamine-induced aggregation and the uptake of 5-hydroxytryptamine and dopamine by human blood platelets.
Boullin DJ; Grimes RP; Orr MW
Br J Pharmacol; 1975 Dec; 55(4):555-7. PubMed ID: 2360
[TBL] [Abstract][Full Text] [Related]
49. Behavior of knock-in mice with a cocaine-insensitive dopamine transporter after virogenetic restoration of cocaine sensitivity in the striatum.
O'Neill B; Tilley MR; Han DD; Thirtamara-Rajamani K; Hill ER; Bishop GA; Zhou FM; During MJ; Gu HH
Neuropharmacology; 2014 Apr; 79():626-33. PubMed ID: 24412674
[TBL] [Abstract][Full Text] [Related]
50. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
Darmani NA; Reeves SL
Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
[TBL] [Abstract][Full Text] [Related]
51. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
Budygin EA; John CE; Mateo Y; Jones SR
J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
[TBL] [Abstract][Full Text] [Related]
52. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation.
Berger JS; Becker RC; Kuhn C; Helms MJ; Ortel TL; Williams R
Thromb Haemost; 2013 Jan; 109(1):85-92. PubMed ID: 23223800
[TBL] [Abstract][Full Text] [Related]
53. Activation of human platelets by cocaine.
Kugelmass AD; Oda A; Monahan K; Cabral C; Ware JA
Circulation; 1993 Sep; 88(3):876-83. PubMed ID: 7689042
[TBL] [Abstract][Full Text] [Related]
54. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat.
Paczkowski NJ; Vuocolo HE; Bryan-Lluka LJ
Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar; 353(4):423-30. PubMed ID: 8935709
[TBL] [Abstract][Full Text] [Related]
55. Dynamics of platelet mobilisation into lungs in response to 5-hydroxytryptamine (serotonin) in mice.
Yu Z; Ohba M; Nakamura M; Sasano T; Ono M; Sugawara S; Endo Y
Thromb Haemost; 2009 Dec; 102(6):1251-8. PubMed ID: 19967158
[TBL] [Abstract][Full Text] [Related]
56. Regulation of central synaptic transmission by 5-HT(1B) auto- and heteroreceptors.
Morikawa H; Manzoni OJ; Crabbe JC; Williams JT
Mol Pharmacol; 2000 Dec; 58(6):1271-8. PubMed ID: 11093763
[TBL] [Abstract][Full Text] [Related]
57. 5HT2-receptors and serotonin release: their role in human platelet aggregation.
Cerrito F; Lazzaro MP; Gaudio E; Arminio P; Aloisi G
Life Sci; 1993; 53(3):209-15. PubMed ID: 8321084
[TBL] [Abstract][Full Text] [Related]
58. Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17).
Duerschmied D; Canault M; Lievens D; Brill A; Cifuni SM; Bader M; Wagner DD
J Thromb Haemost; 2009 Jul; 7(7):1163-71. PubMed ID: 19426283
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
de Clerck F; David JL; Janssen PA
Agents Actions; 1982 Jul; 12(3):388-97. PubMed ID: 6215842
[TBL] [Abstract][Full Text] [Related]
60. Further SAR studies of piperidine-based analogues of cocaine. 2. Potent dopamine and serotonin reuptake inhibitors.
Tamiz AP; Zhang J; Flippen-Anderson JL; Zhang M; Johnson KM; Deschaux O; Tella S; Kozikowski AP
J Med Chem; 2000 Mar; 43(6):1215-22. PubMed ID: 10737754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
